Back to Results
First PageMeta Content
Antibiotics / Glycopeptide antibiotics / Gram-positive bacteria / Pathogenic bacteria / Dalbavancin / Antibiotic resistance / Durata Therapeutics / Quinolone / Clostridium difficile / Bacteria / Biology / Microbiology


A BACTERIAL BATTLE The regulatory path to approving new antibiotics has been cleared, but work still remains to rebuild a HEALTHY DRUG PIPELINE was too toxic,” says Glenn Tillotson, a senior partner at the life science
Add to Reading List

Document Date: 2014-06-12 14:00:02

Open Document

File Size: 931,04 KB

Share Result on Facebook

City

San Diego / /

Company

Novartis / Biosearch Italia / Especially Demanding Applications Jost Chemical Co. / Roche / GlaxoSmithKline / Durata / Merck / Tetraphase / Theravance / Arsanis Biosciences / Merck & Co. / Polyphor / ACS / Cubist Pharmaceuticals / FDA’s / Medicines Co. / Pfizer / Actelion / TranScrip Partners / Vicuron Pharmaceuticals / AstraZeneca / Enanta Pharmaceuticals / Spectroscopy J-KEM Scientifc Inc. / /

Continent

Europe / /

Currency

USD / /

/

Event

FDA Phase / M&A / Product Issues / Product Recall / /

Facility

Serious hospital Prodrug / W Port / BUILDING BLOCKS Over / /

/

IndustryTerm

pharmaceutical industry / chemical entities / infectious disease development / chemical substrate / e-commerce portal / qualified infectious disease products / /

MedicalCondition

aeruginosa airway infection / intra-abdominal infections / minor injuries / I KEY Company Drug candidate Infection / pneumonia / bacterial infections / resistant infections / Pseudomonas infections / drug-resistant gonorrhea / diseases / infection / infectious disease / qualified infectious disease products / KaloBios KB001-A Chronic Pseudomonas / Pseudomonas / epidemic / qualified infectious disease / skin infections / cystic fibrosis / infections / orphan diseases / skin infection / grampositive infections / cut / bacterial infection / infectious diseases / serious infection / /

MedicalTreatment

bone marrow transplants / antibiotics / /

Organization

FDA’s office of Antimicrobial Products / World Health Organization / Food & Drug Administration / Congress / Securities & Exchange Commission / Tufts University School of Medicine / /

Person

David Payne / Glenn Tillotson / Daria Hazuda / Guy Macdonald / John Rex / Marion Merrell Dow / Infection / Helen Boucher / LISA M. JARVIS / Edward M. Cox / Michael W. Dunne / Eszter Nagy / Janet Hammond / /

/

Position

president / chief executive officer / head of infectious disease discovery efforts / head / head of infection / infectious diseases specialist / chief medical officer / director / senior partner / head of the company’s infectious diseases translational unit / candidate / head of antibacterials discovery unit / /

Product

Monosulfactam / NDA / LFF571 / POL7080 / Company Drug / MK-6072 / AFN-1720 / MEDI4893 / /

ProgrammingLanguage

C / /

ProvinceOrState

California / /

Technology

drug discovery / antibodies / rational drug design / AVI / /

URL

www.organo.in / www.jostchemical.com / http /

SocialTag